| Naoya Izawa, PSYD | |
|
8285 Sw Nimbus Ave Ste 130, Beaverton, OR 97008-6428 | |
| (503) 610-2044 | |
| Not Available |
| Full Name | Naoya Izawa |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 8285 Sw Nimbus Ave Ste 130, Beaverton, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851151484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 3819 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Naoya Izawa, PSYD 399 E 10th Ave, Eugene, OR 97401-3380 Ph: () - | Naoya Izawa, PSYD 8285 Sw Nimbus Ave Ste 130, Beaverton, OR 97008-6428 Ph: (503) 610-2044 |
News Archive
New guidelines aimed at dealing with asthma have been released by government health experts in the United States.
Almost 40 percent of Americans at risk for colon cancer are not getting screened. StopColonCancerNow.com, a national public awareness campaign for colon cancer prevention and screening, is working to improve that statistic by urging anyone 50 and older to get screened during National Colon Cancer Awareness Month in March.
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Viral hepatitis affects more than 500 million people worldwide and is a cause of liver failure and liver cancer. While vaccines are available for hepatitis A and B, this is not the case for hepatitis C, which affects as much as two percent of the population in the U.S. Scientists today are reporting discovery of a virus related to hepatitis C in Asian bats, which may provide insights into the origins of the hepatitis C virus and into the mechanisms by which infectious diseases move from other species to humans.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
› Verified 4 days ago
Dr. Sheryl Jane Chomak, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10700 Sw Beaverton Hillsdale Hwy, Suite 500, Beaverton, OR 97005 Phone: 503-626-4031 Fax: 503-641-1071 | |
Dr. Allan F. Chino, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 195 Sw 144th Ave, Beaverton, OR 97006 Phone: 503-705-7136 | |
Dr. Jaime Larson, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12555 Sw 3rd St, Beaverton, OR 97005 Phone: 503-928-4275 | |
Dr. Minkyeong Shin, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8285 Sw Nimbus Ave Ste 130, Beaverton, OR 97008 Phone: 503-610-2044 | |
Dr. Alex Bloom, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 8285 Sw Nimbus Ave Ste 130, Beaverton, OR 97008 Phone: 503-610-2044 Fax: 503-296-2102 | |
Dr. Steven W Spotts, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4900 Sw Griffith Dr, Ste 265, Beaverton, OR 97005 Phone: 503-526-9304 | |
Dr. Danielle Grover, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10445 Sw Canyon Rd, Beaverton, OR 97005 Phone: 971-380-5669 |